On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site ; volume:14 ; pages:930-954
Beilstein journal of organic chemistry ; 14, 930-954
- Klassifikation
-
Chemie
- DOI
-
10.3762/bjoc.14.80
- URN
-
urn:nbn:de:101:1-2018091309344644066569
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Ähnliche Objekte (12)
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates
Antibody–drug conjugates—the magic bullet?
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates
Antibody–drug conjugates—the magic bullet?
Development of peptide-drug conjugates targeting mitochondria
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Antibody–drug conjugates in ovarian cancer
Chemoselective synthesis of functional drug conjugates